Different interactions of platelets with arterial and venous coronary bypass vessels
- 20 April 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 337 (8747), 939-943
- https://doi.org/10.1016/0140-6736(91)91571-b
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein.Circulation Research, 1991
- Platelets and Thrombolytic TherapyNew England Journal of Medicine, 1990
- Endothelium-derived relaxing factor and protection against contractions induced by histamine and serotonin in the human internal mammary artery and in the saphenous vein.Circulation, 1989
- Difference between Endothelium-Dependent Relaxation in Arterial and in Venous Coronary Bypass GraftsNew England Journal of Medicine, 1988
- ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUMThe Lancet, 1987
- Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in plateletsBritish Journal of Pharmacology, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.Circulation, 1986
- Influence of the Internal-Mammary-Artery Graft on 10-Year Survival and Other Cardiac EventsNew England Journal of Medicine, 1986
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980